RecruitingNCT06584097
COMparative Performance of General Purpose Models
COMparative Performance of General Purpose Models for Propofol And REmifentanil in Neurosurgical Patients Admitted to the Intensive Care Unit
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Enrollment
42 participants
Start Date
Oct 2, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To compare the performance of the Eleveld models for propofol and remifentanil on neurosurgery patients admitted to intensive care with their intraoperative performance.
Eligibility
Inclusion Criteria1
- Adult patients undergoing elective neurosurgical procedures with an expected sedation after surgery of > 12 hours • Requirement for an arterial line
Exclusion Criteria6
- Pregnancy
- Known sensitivity or allergy to propofol or remifentanil
- Patient participating in research for which a period of exclusion is currently required by other study protocol, ethical committee or health authority.
- Age < 18 years old
- Patients subjected to infusion of propofol and/or remifentanil not delivered through TCI pumps before the inclusion
- Patients exposed to other sedatives (benzodiazepines, volatile anesthetics, quetiapine) before the inclusion
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06584097